EG ·
MITASHE 1MGML 3AMP
MITASHE 1MGML 3AMP
Composition
These source-reported data require scientific review and are not treatment advice.
CEFEPIME
· AMOUNT_PER_UNIT
Registration
Packages and prices
MITASHE 1MGML 3AMP
Explainable alternatives
Candidates are informational and are not automatic authorization for substitution or dispensing.
| Product | Match | Differences | Price |
|---|---|---|---|
| Cefepime 500 gm 1 vial | SAME_ACTIVE_INGREDIENT_SET | dosage_form | — EGP |
| FORCETEX 1 G VIAL | SAME_ACTIVE_INGREDIENT_SET | dosage_form | — EGP |
| WINCEF 1000 MG I.M VIAL | SAME_ACTIVE_INGREDIENT_SET | dosage_form | — EGP |
| vanzapro 2g vial iv | SAME_ACTIVE_INGREDIENT_SET | dosage_form | — EGP |
| MAXIPIME 500 GM 1 VIAL | SAME_ACTIVE_INGREDIENT_SET | dosage_form | — EGP |
| SPECTRACEF 1 GM VIAL | SAME_ACTIVE_INGREDIENT_SET | dosage_form, route | — EGP |
| curafep 2gm vial | SAME_ACTIVE_INGREDIENT_SET | dosage_form | — EGP |
| VANZAPRO 1GM IM/IV INJECTION | SAME_ACTIVE_INGREDIENT_SET | dosage_form | — EGP |
| spectracef 0.5gm vial | SAME_ACTIVE_INGREDIENT_SET | dosage_form, route | — EGP |
| MAXIPIME 2 GM AMP | SAME_ACTIVE_INGREDIENT_SET | dosage_form | — EGP |
| VANZAPRO 2 G VIAL | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis, dosage_form, route | — EGP |
| onsime 500 mg vial | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis, dosage_form, route | — EGP |